Description
Proportion of lung cancer patients tested for Epidermal Growth Factor Receptor (EGFR) for active treatment of non-small cell lung cancer (excluding squamous cell cancer, stage IV). For the key figure, the National Lung Cancer Registry has set a higher target level of 95% and a lower target level of 60%.
Resources
| Name | Format | Description | Link |
|---|---|---|---|
| Data service with information in Swedish | Unknown | Open resource |